Cargando…

Prediction of BRCA Gene Mutation in Breast Cancer Based on Deep Learning and Histopathology Images

BACKGROUND: Breast cancer is one of the most common cancers and the leading cause of death from cancer among women worldwide. The genetic predisposition to breast cancer may be associated with a mutation in particular genes such as gene BRCA1/2. Patients who carry a germline pathogenic mutation in B...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaoxiao, Zou, Chong, Zhang, Yi, Li, Xiuqing, Wang, Chenxi, Ke, Fei, Chen, Jie, Wang, Wei, Wang, Dian, Xu, Xinyu, Xie, Ling, Zhang, Yifen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329536/ https://www.ncbi.nlm.nih.gov/pubmed/34354733 http://dx.doi.org/10.3389/fgene.2021.661109

Ejemplares similares

Deep Learning Based Analysis of Histopathological Images of Breast Cancer
por: Xie, Juanying, et al.
Publicado: (2019)

BRCA-1 and BRCA-2 mutation bedside detection and breast cancer clinical primary prevention
por: Stagnaro, Sergio, et al.
Publicado: (2013)

BRCA1 and BRCA2 mutations in Scotland and Northern Ireland
Publicado: (2003)

Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing
por: Kang, Hyunseok P., et al.
Publicado: (2016)

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
por: Iqbal, J, et al.
Publicado: (2012)

A Novel Germline Compound Heterozygous Mutation of BRCA2 Gene Associated With Familial Peripheral Neuroblastic Tumors in Two Siblings
por: Yang, Yeran, et al.
Publicado: (2021)

Predicting Mutational Status of Driver and Suppressor Genes Directly from Histopathology With Deep Learning: A Systematic Study Across 23 Solid Tumor Types
por: Loeffler, Chiara Maria Lavinia, et al.
Publicado: (2022)

Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer
por: Nicolussi, Arianna, et al.
Publicado: (2019)

DeepLRHE: A Deep Convolutional Neural Network Framework to Evaluate the Risk of Lung Cancer Recurrence and Metastasis From Histopathology Images
por: Wu, Zhijun, et al.
Publicado: (2020)

AMP-EBiLSTM: employing novel deep learning strategies for the accurate prediction of antimicrobial peptides
por: Wang, Yuanda, et al.
Publicado: (2023)

Dealing with the unexpected: consumer responses to direct-access BRCA mutation testing
por: Francke, Uta, et al.
Publicado: (2013)

BrcaSeg: A Deep Learning Approach for Tissue Quantification and Genomic Correlations of Histopathological Images
por: Lu, Zixiao, et al.
Publicado: (2021)

Identification and Validation of Efficacy of Immunological Therapy for Lung Cancer From Histopathological Images Based on Deep Learning
por: Yang, Yachao, et al.
Publicado: (2021)

The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study
por: Iqbal, Javaid, et al.
Publicado: (2016)

Distinct clinicopathological differences between early gastric cardiac and non-cardiac carcinomas: a single-center retrospective study of 329 radical resection cases
por: Wang, Yaohui, et al.
Publicado: (2020)

BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families
por: Claes, K, et al.
Publicado: (2004)

Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions
por: Su, Yifan, et al.
Publicado: (2021)

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
por: Mitra, A, et al.
Publicado: (2008)

Cardiovascular Abnormalities and Gene Mutations in Children With Noonan Syndrome
por: Sun, Ling, et al.
Publicado: (2022)

Germline BRCA1 Mutation Detected in a Multiple Endocrine Neoplasia Type 2 Case With RET Codon 634 Mutation
por: Sarkadi, Balázs, et al.
Publicado: (2019)

Germline truncating mutations in both MSH2 and BRCA2 in a single kindred
por: Thiffault, I, et al.
Publicado: (2004)

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
por: Osorio, A, et al.
Publicado: (2009)

Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
por: Osorio, A, et al.
Publicado: (2011)

Optimal selection for BRCA1 and BRCA2 mutation testing using a combination of ‘easy to apply’ probability models
por: Bodmer, D, et al.
Publicado: (2006)

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study
por: Phelan, C M, et al.
Publicado: (2014)

The Impact of BRCA1- and BRCA2 Mutations on Ovarian Reserve Status
por: C.E, Drechsel Katja, et al.
Publicado: (2022)

Prediction of metal ion ligand binding residues by adding disorder value and propensity factors based on deep learning algorithm
por: Hao, Sixi, et al.
Publicado: (2022)

Germline BRCA1 mutations increase prostate cancer risk
por: Leongamornlert, D, et al.
Publicado: (2012)

Identification of Novel BRCA1 and RAD50 Mutations Associated With Breast Cancer Predisposition in Tunisian Patients
por: Mighri, Najah, et al.
Publicado: (2020)

BRCA2 gene mutations in families with aggregations of breast and stomach cancers
por: Jakubowska, A, et al.
Publicado: (2002)

Rapid progression of prostate cancer in men with a BRCA2 mutation
por: Narod, S A, et al.
Publicado: (2008)

Preliminary investigation of the diagnosis and gene function of deep learning PTPN11 gene mutation syndrome deafness
por: Wu, Xionghui, et al.
Publicado: (2023)

Intelligent Health Care: Applications of Deep Learning in Computational Medicine
por: Yang, Sijie, et al.
Publicado: (2021)

Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia
por: Wen, Wei Xiong, et al.
Publicado: (2018)

A comparative study of germline BRCA1 and BRCA2 mutation screening methods in use in 20 European clinical diagnostic laboratories
por: Ellison, Gillian, et al.
Publicado: (2017)

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2005)

Identification of Deep-Intronic Splice Mutations in a Large Cohort of Patients With Inherited Retinal Diseases
por: Qian, Xinye, et al.
Publicado: (2021)

Spectrum of Mutations in Pediatric Non-glomerular Chronic Kidney Disease Stages 2–5
por: Wang, Xiaoyuan, et al.
Publicado: (2021)

DeepLION: Deep Multi-Instance Learning Improves the Prediction of Cancer-Associated T Cell Receptors for Accurate Cancer Detection
por: Xu, Ying, et al.
Publicado: (2022)

Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12
por: Gallardo-Rincón, Dolores, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n6e428p22miq0foeqb38b7ikfh